Equity - Common Stock Warrants (Details) - USD ($)				3 Months Ended		12 Months Ended
	Jun. 26, 2023	Apr. 20, 2020	Jul. 17, 2019	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2021	Dec. 31, 2020
Number of Underlying Shares
Outstanding, beginning balance (in shares)				11,308,314		11,308,314	392,155
Outstanding, end balance (in shares)					11,308,314	10,819,742	11,308,314
Weighted Average Exercise Price Per Share
Outstanding, beginning balance (in dollars per share)				$ 1.09		$ 1.09	$ 8.58
Outstanding, end balance (in dollars per share)					$ 1.09	$ 1.14	$ 1.09
June 2023 Pre-Funded Warrants
Number of Underlying Shares
Granted during period (in shares)							637,587
Exercised during period (in shares)							(637,587)
Weighted Average Exercise Price Per Share
Granted during period (in dollars per share)							$ 0.0001
Exercised during period (in dollar per share)							$ 0.0001
June 2023 Warrants
Number of Underlying Shares
Granted during period (in shares)							1,427,587
Outstanding, end balance (in shares)						1,427,587
Weighted Average Exercise Price Per Share
Granted during period (in dollars per share)							$ 1.9
Outstanding, end balance (in dollars per share)						$ 1.9
November 2023 Series A Warrants
Number of Underlying Shares
Granted during period (in shares)							6,000,000
Outstanding, end balance (in shares)						6,000,000
Weighted Average Exercise Price Per Share
Granted during period (in dollars per share)							$ 0.7
Outstanding, end balance (in dollars per share)						$ 0.7
November 2023 Series B Warrants
Number of Underlying Shares
Granted during period (in shares)							3,000,000
Outstanding, end balance (in shares)						3,000,000
Weighted Average Exercise Price Per Share
Granted during period (in dollars per share)							$ 0.7
Outstanding, end balance (in dollars per share)						$ 0.7
November 2023 Pre-Funded Warrants
Number of Underlying Shares
Granted during period (in shares)							1,287,512
Exercised during period (in shares)						(488,572)	(798,940)
Weighted Average Exercise Price Per Share
Granted during period (in dollars per share)							$ 0.0001
Exercised during period (in dollar per share)						$ 0.0001	$ 0.0001
Net proceeds				$ 48.86	$ 70.89
July 2019 Series A Warrants
Number of Underlying Shares
Outstanding, end balance (in shares)						338,155
Weighted Average Exercise Price Per Share
Exchanged during the period (in dollar per share)			$ 8.75
Outstanding, end balance (in dollars per share)						$ 8.75
Registered Offering [Member] | July 2019 Series A Warrants
Number of Underlying Shares
Outstanding, beginning balance (in shares)				338,155		338,155
Exercised during period (in shares)								8,000
Outstanding, end balance (in shares)					338,155	338,155	338,155
Weighted Average Exercise Price Per Share
Warrants Exercise Period			6 months
Warrants to purchase common stock								100,000
Private Placement
Weighted Average Exercise Price Per Share
Outstanding, end balance (in dollars per share)	$ 1.9
Number of common shares which can be purchased with each warrant	1,427,587
Gross proceeds from common stock sale									$ 2,600,000
Private Placement | Series A Warrants
Number of Underlying Shares
Outstanding, beginning balance (in shares)								100,000
Exercised during period (in shares)								56,000	200,000
Outstanding, end balance (in shares)								44,000	100,000
Weighted Average Exercise Price Per Share
Net proceeds								$ 400,000
Private Placement | Series B Warrants
Number of Underlying Shares
Outstanding, beginning balance (in shares)								10,000
Exercised during period (in shares)									140,000
Outstanding, end balance (in shares)								10,000	10,000
Common Stock | Registered Offering [Member] | July 2019 Series A Warrants
Weighted Average Exercise Price Per Share
Aggregate number of common stock sold (Shares)			346,155
Common Stock | Private Placement
Weighted Average Exercise Price Per Share
Aggregate number of common stock sold (Shares)		600,000
Warrants to purchase common stock		450,000
Common Stock | Private Placement | Series A Warrants
Weighted Average Exercise Price Per Share
Warrants to purchase common stock		300,000
Common Stock | Private Placement | Series B Warrants
Weighted Average Exercise Price Per Share
Warrants to purchase common stock		150,000